NicOx gets milestone for starting Phase I

NicOx (NM:Nicox) started a 60-patient Swedish Phase I trial of HCT-3012, an NO-NSAID to treat pain and inflammation. The double-blind, placebo controlled, dose escalating trial will assess safety and ...